Deutsche Stiftung Organtransplantation, Frankfurt am Main, Germany.
Transpl Int. 2023 Sep 4;36:11610. doi: 10.3389/ti.2023.11610. eCollection 2023.
The reporting of serious adverse events (SAE) and serious adverse reactions (SAR) is an essential part of an effective vigilance and surveillance system (V&S) in organ donation and transplantation. All SAE and SAR reported to the German organ procurement organization (DSO) between 2016 and 2022 were analyzed. In case of a possible transmission of a disease to one or more recipients, an assessment of imputability was done according to the grading system of the US Disease Transmission Advisory Committee (DTAC). 543 SAE and SAR cases were reported to the DSO and analyzed in detail. 53 of the 543 reports (9.8%) were proven or probable (P/P) transmissions of infectious diseases, malignancies or other diseases to 75 recipients. Infections were the most frequently reported P/P disease transmission occurrences (30/53, 57%). In case of disease transmission, the mortality of the recipients was high (17/75, 23%), especially when a malignant disease was transmitted (11/22, 50 %). Donor-Derived disease transmission is a rare event (53/8,519; 0.6 %), but when it occurs can lead to significant morbidity and mortality.
严重不良事件(SAE)和严重不良反应(SAR)的报告是器官捐献和移植中有效警戒和监测系统(V&S)的重要组成部分。对 2016 年至 2022 年期间向德国器官采购组织(DSO)报告的所有 SAE 和 SAR 进行了分析。如果一种或多种受者可能发生疾病传播,则根据美国疾病传播咨询委员会(DTAC)的分级系统对可归因性进行评估。向 DSO 报告并详细分析了 543 例 SAE 和 SAR 病例。在 543 份报告中,有 53 份(9.8%)被证实或可能(P/P)为传染病、恶性肿瘤或其他疾病向 75 名受者传播。感染是最常报告的 P/P 疾病传播事件(30/53,57%)。发生疾病传播时,受者死亡率很高(17/75,23%),尤其是恶性疾病传播时(11/22,50%)。供体源性疾病传播是一种罕见事件(53/8519;0.6%),但发生时会导致严重的发病率和死亡率。